656
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

The coverage of influenza and pneumococcal vaccinations among people living with HIV in Denmark: A single-center cross-sectional survey

ORCID Icon, ORCID Icon & ORCID Icon
Pages 2700-2705 | Received 10 Dec 2020, Accepted 20 Feb 2021, Published online: 24 Mar 2021

References

  • Backhaus E, Berg S, Andersson R, Ockborn G, Malmstrom P, Dahl M, Nasic S, Trollfors B. Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors. BMC Infect Dis. 2016;16:367
  • Klemets P, Lyytikainen O, Ruutu P, Ollgren J, Nuorti JP. Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies. BMC Infect Dis. 2008;8:96.
  • Giner AM, Kuster SP, Zbinden R, Ruef C, Ledergerber B, Weber R. Initial management of and outcome in patients with pneumococcal bacteremia: a retrospective study at a Swiss university hospital, 2003-2009. Infection. 2011;39:519–26.
  • Sadlier C, O’Connell S, Kelleher M, Bergin C. Incidence and risk factors for invasive pneumococcal disease in HIV-positive individuals in the era of highly active antiretroviral therapy. Int J STD AIDS. 2019;30:472–78.
  • Marcus JL, Baxter R, Leyden WA, Muthulingam D, Yee A, Horberg MA, Klein DB, Towner WJ, Chao CR, Quesenberry CP. Invasive pneumococcal disease among HIV-infected and HIV-uninfected adults in a large integrated healthcare system. AIDS Patient Care STDS. 2016;30:463–70
  • Harboe ZB, Larsen MV, Ladelund S, Kronborg G, Konradsen HB, Gerstoft J, Larsen CS, Pedersen C, Pedersen G, Obel N, et al. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users. Clin Infect Dis. 2014;59:1168–76
  • Ho A, Mallewa J, Peterson I, SanJoaquin M, Garg S, Bar-Zeev N, Menyere M, Alaerts M, Mapurisa G, Chilombe M, et al. Epidemiology of severe acute respiratory illness and risk factors for influenza infection and clinical severity among adults in Malawi, 2011–2013. Am J Trop Med Hyg. 2018;99: 772–79
  • Tempia S, Walaza S, Moyes J, Cohen AL, von Mollendorf C, Treurnicht FK, Venter M, Pretorius M, Hellferscee O, Mtshali S, et al. Risk factors for influenza-associated severe acute respiratory illness hospitalization in South Africa, 2012-2015. Open Forum Infect Dis. 2017;4:262
  • Peters PJ, Skarbinski J, Louie JK, Jain S, Roland M, Jani SG, Finelli L, Brooks JT. HIV-infected hospitalized patients with 2009 pandemic influenza A (pH1N1)–United States, spring and summer 2009. Clin Infect Dis. 2011;52(Suppl 1):S183–8
  • Geretti AM, Brook G, Cameron C, Chadwick D, French N, Heyderman R, Ho A, Hunter M, Ladhani S, Lawton M, et al. British HIV association guidelines on the use of vaccines in HIV-positive adults 2015. HIV Med. 2016;17(Suppl 3):s2–s81
  • Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:e44–100
  • Rosenstock IM. Why people use health services. Milbank Mem Fund Q. 1966;44:94–127.
  • Tsutsui Y, Benzion U, Shahrabani S, Din GY. A policy to promote influenza vaccination: a behavioral economic approach. Health Policy (New York). 2010;97:238–49.
  • Althoff KN, Anastos K, Nelson KE, Celentano DD, Sharp GB, Greenblatt RM, French AL, Diamond DJ, Holman S, Young M, et al. Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons. Prev Med. 2010;50:223–29
  • Ellis J, Brown J, Smith C, Snell L, Capocci S, Ferro F, Ferreira J, Marshall N, Webster D, Johnson M, et al. Influenza immunisation: knowledge and actions taken by UK HIV-positive adults. HIV Med. 2016;17:397–99
  • La EM, Trantham L, Kurosky SK, Odom D, Aris E, Hogea C. An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability. Hum Vaccin Immunother. 2018;14:430–41.
  • Gallagher KM, Juhasz M, Harris NS, Teshale EH. Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002. J Infect Dis. 2007;196:339–46.
  • Harrison N, Poeppl W, Herkner H, Tillhof KD, Grabmeier-Pfistershammer K, Rieger A, Forstner C, Burgmann H, Lagler H. Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey. HIV Med. 2017;18:500–06
  • Mohseni-Zadeh M, Rey D, Batard ML, Beck Wirth G, Partisani ML, Lang JM, Hansmann Y, Christmann D, Martinot M. Inadequate vaccination coverage in a French cohort of HIV positive patients. Med Mal Infect. 2010;40:683–90
  • Tsachouridou O, Georgiou A, Naoum S, Vasdeki D, Papagianni M, Kotoreni G, Forozidou E, Tsoukra P, Gogou C, Chatzidimitriou D, et al. Factors associated with poor adherence to vaccination against hepatitis viruses, streptococcus pneumoniae and seasonal influenza in HIV-infected adults. Hum Vaccin Immunother. 2019;15:295–304
  • ECDC. Seasonal influenza vaccination and antiviral use in EU/EEA Member States [accessed 17 Aug. 2020]. https://www.ecdc.europa.eu/sites/default/files/documents/seasonal-influenza-antiviral-use-2018.pdf.
  • Boey L, Bosmans E, Ferreira LB, Heyvaert N, Nelen M, Smans L, Tuerlinckx H, Roelants M, Claes K, Derdelinckx I, et al. Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups. Hum Vaccin Immunother. 2020;16;2136–2143
  • Valour F, Cotte L, Voirin N, Godinot M, Ader F, Ferry T, Vanhems P, Chidiac C. Vaccination coverage against hepatitis A and B viruses, streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients. Vaccine. 2014;32:4558–64
  • Statens serum institut. Influenza. Vaccinationstilslutning. 2020 [accessed 17 Aug, 2020]. https://statistik.ssi.dk//sygdomsdata#!/?vaccination=14&sex=3&agegroup=10&landsdel=100&xaxis=Season&show=Graph&season=2016%7C2016&datatype=Vaccination.
  • Statens Serum Institut. Pneumokokvaccination uden for børnevaccinationsprogrammet i Danmark. 2020, [accessed 17 Aug, 2020]. https://www.ssi.dk/-/media/arkiv/dk/vaccination/risikogrupper/rapport-vedr-pneumokokvacc-udenfor-boernevaccprogram-14042020.pdf?la=da.
  • Molloy A, Curtis H, Burns F, Freedman A. Routine monitoring and assessment of adults living with HIV: results of the British HIV Association (BHIVA) national audit 2015. BMC Infect Dis. 2017;17:619.
  • Quinn KJ, McCarty EJ, Quah SP, Emerson CR, Donnelly CM. Managing vaccines: defining the remit of primary care and specialist HIV clinics in the delivery of immunization to individuals with HIV infection. Int J STD AIDS. 2012;23:136–37.
  • Vivancos-Gallego MJ, Muriel A, Serrano-Villar S, Moreno-Zamora A, Pérez-Elías MJ, Quereda C, Casado JL, Sánchez-Conde M, Del Campo S, Dronda F, et al. Pneumococcal vaccination in adult people living with HIV on suppressive antiretroviral therapy: a case-control study. Int J STD AIDS. 2020;31:174–82
  • Cotte L, Voirin N, Richard C, Brochier C, Schlienger I, Lack P, Lina B, Vanhems P, Zoulim F. Factors associated with pandemic influenza A/H1N1 vaccine coverage in a French cohort of HIV-infected patients. Vaccine. 2011;29: 5638–44
  • Lim PL, Tan J, Yusoff Y, Win MK, Chow A. Rates and predictors for influenza vaccine prescriptions among HIV-infected clinic patients in Singapore. Ann Acad Med Singapore. 2013;42:173–77.
  • Duque J, Gaga S, Clark D, Muller M, Kuwane B, Cohen C, Walaza S, Tempia S, Ramatoboe P, Furumele T, et al. Knowledge, attitudes and practices of South African healthcare workers regarding the prevention and treatment of influenza among HIV-infected individuals. PloS One. 2017;12:e0173983

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.